Interview | Futures in Focus: The Technologies and Strategies Shaping Clinical Trial Supply [updated Oct 2025]

The clinical trial supply chain is undergoing a radical transformation. With the complexity of multi-indication treatments and rare disease trials driving new challenges, innovative technologies and strategies are now essential. As we head into 2026, these pressures are intensifying, making advanced solutions more critical than ever. In this interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how advanced tools and patient-centric approaches are reshaping every link in the supply chain.

Download this interview to learn more about:

• Transforming Clinical Supply Chains: AI and automation streamline data collection, enhance forecasting accuracy, and reduce manual inefficiencies to ensure timely supplies and improved operational performance.
• Decentralised Trials & Direct-to-Patient Models: Direct-to-patient approaches address recruitment challenges and complex multi-indication studies, elevating enrolment, retention, and overall supply chain effectiveness.
• Integrated Systems & Sustainability: Scalable, eco-friendly systems overcome packaging, regulatory, and drug return challenges while ensuring global access and robust data integrity.